Please assess the completion status of the following clinical trial:

Trial Title: Trial Comparing Start Stimulation of Recombinant Follicle Stimulating Hormone (rFSH) on Cycle Day 2 Versus Cycle Day 5 in In Vitro Fertilization (IVF)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Female age \< 36 years~* FSH \< 12 IU/l~* BMI 18-29 kg/m2~* Regular cycle (25-35 days)~* No major uterine or ovarian abnormalities~* No previous IVF cycles~* Written informed consent~Exclusion Criteria:~* Oocyte donation~* Medical contra indication for pregnancy or IVF treatment~* Endometriosis ≥ grade 3~* Polycystic Ovarium Syndrome (PCOS)~* Endocrine or metabolic abnormalities (pituitary, adrenal, pancreas, liver or kidney)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 36 Years
- Healthy Volunteers: t

Study Arms:
- Start rFSH cycle day 2 (Type: EXPERIMENTAL): None
- Start rFSH on cycle day 5 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).